Periodic Reporting for period 1 - Lottare GBM (LOcalized Targeted Therapy to Avoid REcurrent GlioBlastoma Multiforme)

TargTex’s therapy for Glioblastoma Multiforme (GBM) addresses the most common type of malignant primary brain tumor affecting nearly a quarter of a million patients globally. After diagnosis, these patients go through surgical resection, followed by radiotherapy and...